Control of hypertension and dyslipidemia among patients with hypertension with and without metabolic syndrome, diabetes, and cardiovascular disease

被引：0
|
作者：
Wong, ND
Pio, JR
Franklin, SS
Tang, S
Williams, GR
机构：
[1] Univ Calif Irvine, Irvine, CA USA
[2] Pfizer Pharmaceut Inc, New York, NY USA
来源：
CIRCULATION | 2005年 / 112卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3173
引用
收藏
页码：U741 / U741
页数：1
相关论文
共 50 条
  • [41] Formalized interconnected guidelines on cardiovascular disease prevention and those for management of diabetes, dyslipidemia and hypertension
    Peleska, J.
    Anger, Z.
    Buchtela, D.
    Tomeckova, M.
    Vesely, A.
    Zvarova, J.
    JOURNAL OF HYPERTENSION, 2006, 24 : S172 - S172
  • [42] Prevalence of comorbid hypertension and dyslipidemia and associated cardiovascular disease
    Johnson, ML
    Pietz, K
    Battleman, DS
    Beyth, RJ
    AMERICAN JOURNAL OF MANAGED CARE, 2004, 10 (12): : 926 - 932
  • [43] The importance of managing hypertension and dyslipidemia to decrease cardiovascular disease
    Kostis, John B.
    CARDIOVASCULAR DRUGS AND THERAPY, 2007, 21 (04) : 297 - 309
  • [44] The Importance of Managing Hypertension and Dyslipidemia to Decrease Cardiovascular Disease
    John B. Kostis
    Cardiovascular Drugs and Therapy, 2007, 21 : 297 - 309
  • [45] Coronary microvascular dysfunction in patients with diabetes, hypertension and metabolic syndrome
    Sucato, Vincenzo
    Novo, Giuseppina
    Evola, Salvatore
    Novo, Salvatore
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 186 : 96 - 97
  • [46] Tight Versus Standard Blood Pressure Control in Patients With Hypertension With and Without Cardiovascular Disease
    Reboldi, Gianpaolo
    Angeli, Fabio
    de Simone, Giovanni
    Staessen, Jan A.
    Verdecchia, Paolo
    HYPERTENSION, 2014, 63 (03) : 475 - 482
  • [47] Preventing cardiovascular disease among Canadians: Is the treatment of hypertension or dyslipidemia cost-effective?
    Grover, Steven
    Coupal, Louis
    Lowensteyn, Ilka
    CANADIAN JOURNAL OF CARDIOLOGY, 2008, 24 (12) : 891 - 898
  • [48] Prevalence of Metabolic Syndrome in the Mediterranean Region of Turkey: Evaluation of Hypertension, Diabetes Mellitus, Obesity, and Dyslipidemia
    Guendogan, Kuersat
    Bayram, Fahri
    Capak, Mehmet
    Tanriverdi, Fatih
    Karaman, Ahmet
    Ozturk, Ahmet
    Altunbas, Hasan
    Goekce, Cumali
    Kalkan, Ali
    Yazici, Cevad
    METABOLIC SYNDROME AND RELATED DISORDERS, 2009, 7 (05) : 427 - 433
  • [49] The Association Between Measurements of Body Composition and the Prevalence of Hypertension, Diabetes and Dyslipidemia in Patients Without Coronary Artery Disease
    Bianchettin, Rosana G.
    Medina-Inojosa, Betsy
    Sheffeh, Mohammad Ali
    De Leon, Andrea
    Lei, Sha
    Johnson, Lynne A.
    Saeidifard, Farzane
    Suarez, Audry Chacin
    Medina-Inojosa, Jose R.
    Lopez-Jimenez, Francisco
    CIRCULATION, 2022, 146
  • [50] Preventing cardiovascular disease among Canadians: What are the potential benefits of treating hypertension or dyslipidemia?
    Grover, Steven A.
    Coupal, Louis
    Kaouache, Mohammed
    Lowensteyn, Ilka
    CANADIAN JOURNAL OF CARDIOLOGY, 2007, 23 (06) : 467 - 473
12345